Annual Report

Overview

The report highlights Boehringer Ingelheim's strong 2022 performance, with net sales of 24,149 million EUR, a 17.1% increase, and approximately 5.0 billion EUR invested in R&D. The company reports that more than 30 million patients were treated with its products during the year. Its sustainability strategy is organized around More Health, More Potential, and More Green, including a commitment to carbon-neutral company operations covering Scope 1 and 2 by 2030.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services